Lymph Node Ratio Nomogram-Based Prognostic Model for Resected Distal Cholangiocarcinoma-Reference-Cited by-同舟云学术

Lymph Node Ratio Nomogram-Based Prognostic Model for Resected Distal Cholangiocarcinoma

Published:2022-10-17 Issue:5 Volume:235 Page:703-712
ISSN:1072-7515
Container-title:Journal of the American College of Surgeons
language:en
Short-container-title:

Author:

Perez Marc,Hansen Carsten Palnaes,Burdio Fernando,Pellino Gianluca,Pisanu Adolfo,Salvia Roberto,Di Martino Marcello,Abu Hilal Mohammad,Aldrighetti Luca,Ielpo Benedetto,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Surgery

Reference36 articles.

1. 8th edition of the AJCC Cancer Staging manual: Pancreas and hepatobiliary cancers.;Chun;Ann Surg Oncol,2018

2. Reply to: “Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma.”;Bertuccio;J Hepatol,2019

3. Recurrence after resection with curative intent for distal cholangiocarcinoma.;Komaya;Br J Surg,2017

4. Differences in prognostic factors and recurrence patterns after curative-intent resection of perihilar and distal cholangiocarcinomas.;Sallinen;Scand J Surg,2020

5. Prognostic significance of lymph node metastasis and surgical margin status for distal cholangiocarcinoma.;Murakami;J Surg Oncol,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer;Journal of Inflammation Research;2024-08

2. A machine learning predictive model for recurrence of resected distal cholangiocarcinoma: Development and validation of predictive model using artificial intelligence;European Journal of Surgical Oncology;2024-07

3. Survival outcome of patient with pT1N0 biliary tract cancer treated with surgery alone;European Journal of Surgical Oncology;2024-03

4. Review on Lymph Node Metastases, Sentinel Lymph Node Biopsy, and Lymphadenectomy in Sarcoma;Current Oncology;2024-01-05

5. A 3 M Evaluation Protocol for Examining Lymph Nodes in Cancer Patients: Multi-Modal, Multi-Omics, Multi-Stage Approach;Technology in Cancer Research & Treatment;2024-01